Skip to main navigation Skip to search Skip to main content

An open-label, Flexible-dose, long term safety study and Efficacy study of Bifeprunox in the treatment of Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/05 → 06/30/09

Funding

  • Solvay Pharmaceuticals Incorporated: $106,230.00